Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Anti-Cancer Drugs | journal | 0.651 Q2 | 102 | 144 | 375 | 4354 | 881 | 374 | 2.15 | 30.24 | 41.46 | |
52 | Therapeutic Drug Monitoring | journal | 0.649 Q2 | 102 | 130 | 303 | 4819 | 827 | 284 | 2.86 | 37.07 | 44.05 | |
53 | Reading Teacher | journal | 0.642 Q2 | 60 | 94 | 297 | 2131 | 329 | 258 | 1.06 | 22.67 | 80.35 | |
54 | Drug Development and Industrial Pharmacy | journal | 0.628 Q3 | 100 | 200 | 614 | 9321 | 2057 | 613 | 3.19 | 46.61 | 42.10 | |
55 | Journal of Biopharmaceutical Statistics | journal | 0.557 Q3 | 56 | 79 | 256 | 2110 | 185 | 244 | 0.74 | 26.71 | 32.39 | |
56 | Biologicals | journal | 0.503 Q3 | 66 | 75 | 238 | 2222 | 456 | 233 | 1.84 | 29.63 | 42.16 | |
57 | American Journal of Health-System Pharmacy | journal | 0.487 Q3 | 107 | 348 | 1078 | 5224 | 1387 | 862 | 1.33 | 15.01 | 54.20 | |
58 | Clinical Neuropharmacology | journal | 0.486 Q3 | 85 | 49 | 179 | 1149 | 286 | 165 | 1.32 | 23.45 | 35.38 | |
59 | International Journal of Medicinal Mushrooms | journal | 0.471 Q3 | 41 | 110 | 307 | 3926 | 654 | 305 | 2.00 | 35.69 | 44.57 | |
60 | Steroids | journal | 0.469 Q3 | 114 | 141 | 438 | 6408 | 1060 | 433 | 2.59 | 45.45 | 44.34 | |
61 | Current Therapeutic Research | journal | 0.449 Q3 | 46 | 43 | 71 | 1512 | 145 | 63 | 1.71 | 35.16 | 41.46 | |
62 | Journal of AOAC International | journal | 0.432 Q3 | 100 | 94 | 742 | 2779 | 1139 | 710 | 1.58 | 29.56 | 38.99 | |
63 | Chirality | journal | 0.430 Q3 | 83 | 130 | 322 | 5093 | 711 | 319 | 2.27 | 39.18 | 32.56 | |
64 | Drug and Chemical Toxicology | journal | 0.422 Q3 | 54 | 85 | 206 | 4209 | 479 | 206 | 2.47 | 49.52 | 44.71 | |
65 | Journal of Pharmacological and Toxicological Methods | journal | 0.353 Q3 | 83 | 69 | 220 | 2766 | 455 | 217 | 1.79 | 40.09 | 38.50 | |
66 | American Journal of Therapeutics | journal | 0.349 Q3 | 69 | 127 | 535 | 3030 | 515 | 235 | 0.83 | 23.86 | 44.04 | |
67 | Hospital Pharmacy | journal | 0.309 Q3 | 28 | 58 | 260 | 1663 | 263 | 218 | 0.83 | 28.67 | 46.05 | |
68 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 25 | 106 | 1660 | 69 | 106 | 0.74 | 66.40 | 33.33 | |
69 | Medical Letter on Drugs and Therapeutics | journal | 0.246 Q3 | 22 | 100 | 321 | 531 | 138 | 179 | 0.55 | 5.31 | 0.00 | |
70 | Natural Product Communications | journal | 0.221 Q4 | 63 | 297 | 1226 | 10909 | 1169 | 1204 | 1.00 | 36.73 | 43.22 | |
71 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.206 Q4 | 34 | 35 | 98 | 1201 | 97 | 98 | 0.86 | 34.31 | 38.30 | |
72 | Pharmaceutical Chemistry Journal | journal | 0.191 Q4 | 39 | 212 | 584 | 5202 | 387 | 582 | 0.65 | 24.54 | 56.71 | |
73 | Food and Drug Law Journal | journal | 0.171 Q4 | 23 | 0 | 43 | 0 | 35 | 42 | 0.89 | 0.00 | 0.00 | |
74 | Journal of Experimental Therapeutics and Oncology | journal | 0.163 Q4 | 40 | 5 | 77 | 116 | 48 | 77 | 0.50 | 23.20 | 35.71 | |
75 | U.S. Pharmacist | trade journal | 0.129 Q4 | 12 | 133 | 356 | 1451 | 61 | 232 | 0.18 | 10.91 | 54.87 | |
76 | National Toxicology Program technical report series | journal | 0.108 | 22 | 2 | 7 | 0 | 1 | 7 | 0.20 | 0.00 | 0.00 | |
77 | Adverse Drug Reaction Bulletin | journal | 0.101 Q4 | 8 | 6 | 20 | 197 | 0 | 17 | 0.00 | 32.83 | 40.00 | |
78 | Drug Topics | journal | 0.101 Q4 | 8 | 163 | 504 | 48 | 2 | 30 | 0.01 | 0.29 | 64.29 | |
79 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 250 | 537 | 1180 | 2 | 104 | 0.01 | 4.72 | 64.10 | |
80 | NTP Immunotoxicity Technical Report Series | book series | 0 | 3 | 0 | 335 | 0 | 0 | 0.00 | 111.67 | 46.15 | ||
81 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 29 | 7 | 25 | 793 | 51 | 0 | 2.38 | 113.29 | 5.56 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®